- About BME
- Academics Home
- Combined Degrees
- Student Resources
- Industry Home
- Partner Benefits
- Student Design Projects
- Guest Lectures
- BME Interns
- Research Collaborations
- Tech Licensing
- Industry News
- "Women's Radio Network Open Forum" To Feature AxoGen, Inc.
- 3rd Annual Pruitt Research Day
- AxoGen, Inc. Announces Clearance from FDA to Proceed with New Multicenter Comparative Study for Avance® Nerve Graft
- AxoGen, Inc. Announces Completion of a Pilot Clinical Study Assessing Cavernous Nerve Reconstruction with Avance® Nerve Graft
- BioD LLC Makes $1 Million Gift Commitment to UF BME
- BioD Receives U.S. Patent for Unique Placental Tissue Technology
- Dr. Peter McFetridge awarded the Tim Brahm Professorship
- Event Celebrates BioD’s $1 Million Gift to BME
- New Industry Partner: Sigma Aldrich Corporation
- RTI Surgical™ Announces Agreement With Novation
- Record BME Industry Partner Participation at the 4th Annual Pruitt Research Day
- SPECIAL EVENT: “Geraldo Rivera Show” to Feature AxoGen, Inc.
- Stryker Provides Guest Lecture to BME Students
- Contact Us
Dr. Peter McFetridge awarded the Tim Brahm Professorship
The Tim Brahm Endowed Term Professorship in Biomedical Engineering was founded in 2015 to bolster a collaborative research partnership between the University of Florida J. Crayton Pruitt Family Department of Biomedical Engineering and the biotechnology company, BioD.
BioD is a leading regenerative medicine company engaged in the development and commercialization of novel biologic products derived from placental tissues. The professorship is bestowed on faculty members who specializes in regenerative medicine, a revolutionary research area that involves engineering tissues and cells to establish and restore normal functioning. Regenerative medicine is the central focus of this new research collaboration.
Dr. Peter McFetridge’s primary research objective is to engineer viable 'living' tissue and organs for the repair and regeneration of diseased tissues. His groups’ research encompasses angiogenesis and arterial regeneration, articular cartilage development as well as effects on primary and stem cell phenotype driven by mechanical and nutrient variation in the ECM microenvironment. He has received over 850 citations since 2002 along with multiple patent applications and one granted.
Congratulations, Dr. McFetridge!